Cargando…

Conserved HLA binding peptides from five non-structural proteins of SARS-CoV-2—An in silico glance

Coronavirus Disease 2019 (COVID-19) is a dangerous global threat that has no clinically approved treatment yet. Bioinformatics represent an outstanding approach to reveal key immunogenic regions in viral proteins. Here, five severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structural...

Descripción completa

Detalles Bibliográficos
Autor principal:	Marchan, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425717/ https://www.ncbi.nlm.nih.gov/pubmed/32888767 http://dx.doi.org/10.1016/j.humimm.2020.08.001

Ejemplares similares

In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome
por: Alhatlani, Bader Y
Publicado: (2020)

In silico analysis of protein/peptide-based inhalers against SARS-CoV-2
por: Salman, Saad, et al.
Publicado: (2020)

Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective
por: Mahmud, Shafi, et al.
Publicado: (2021)

HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors
por: Lemieux, William, et al.
Publicado: (2023)

Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis
por: Marciniec, Krzysztof, et al.
Publicado: (2020)

Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis
por: Vavougios, George D.
Publicado: (2020)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
por: Muhtar, Eldar, et al.
Publicado: (2021)

In silico exploration of enzymes involved in sialic acid biosynthesis and their possible role in SARS-CoV-2 infection
por: Divya, V.C., et al.
Publicado: (2021)

Two prolonged viremic SARS-CoV-2 infections with conserved viral genome for two months
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
por: Biembengut, Ísis Venturi, et al.
Publicado: (2020)

In silico analysis of mismatches in RT-qPCR assays of 177 SARS-CoV-2 sequences from Brazil
por: Santos, Renan da Silva, et al.
Publicado: (2020)

In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery
por: Khattab, Amira R, et al.
Publicado: (2022)

In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
por: Alanzi, Abdullah R, et al.
Publicado: (2023)

Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes
por: Agrawal, Aditya, et al.
Publicado: (2021)

Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
por: Chen, Chenxiao, et al.
Publicado: (2022)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Codon usage, phylogeny and binding energy estimation predict the evolution of SARS-CoV-2
por: Calcagnile, Matteo, et al.
Publicado: (2021)

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
por: Tomita, Yusuke, et al.
Publicado: (2020)

Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico
por: Quayum, Syeda Tasnim, et al.
Publicado: (2021)

Prospective evaluation of specimen pooling strategy for detection of SARS-CoV-2 using pools of five and six specimens
por: Meletis, Georgios, et al.
Publicado: (2021)

Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug
por: Srikanth, Lokanathan, et al.
Publicado: (2021)

Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
por: Rabbani, Gulam, et al.
Publicado: (2021)

Crystallographic model quality at a glance
por: Urzhumtseva, Ludmila, et al.
Publicado: (2009)

Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs
por: Singh, Vikramjeet, et al.
Publicado: (2021)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S(2)
por: Miró, Òscar, et al.
Publicado: (2021)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

SARS‐CoV‐2‐specific CD8(+) T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
por: Rowntree, Louise C, et al.
Publicado: (2021)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
por: Liu, Haolin, et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Interferon antagonists encoded by SARS-CoV-2 at a glance
por: Lee, Jung-Hyun, et al.
Publicado: (2022)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
por: Krüttgen, Alexander, et al.
Publicado: (2021)

The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant
por: Eldesouki, Raghda E., et al.
Publicado: (2022)

Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha
por: Čretnik, Tjaša Ž, et al.
Publicado: (2022)

Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
por: Pflüger, Lisa Sophie, et al.
Publicado: (2020)

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
por: Andersson, Maria, et al.
Publicado: (2023)

Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: Single-center study
por: Shah, Sadia Z., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pthm10098bqtub2l15qsv5upb7